[go: up one dir, main page]

GB201710410D0 - Inorganic polyphosphate formulations for use in the treatment of alzheimer disease - Google Patents

Inorganic polyphosphate formulations for use in the treatment of alzheimer disease

Info

Publication number
GB201710410D0
GB201710410D0 GBGB1710410.0A GB201710410A GB201710410D0 GB 201710410 D0 GB201710410 D0 GB 201710410D0 GB 201710410 A GB201710410 A GB 201710410A GB 201710410 D0 GB201710410 D0 GB 201710410D0
Authority
GB
United Kingdom
Prior art keywords
treatment
alzheimer disease
inorganic polyphosphate
formulations
polyphosphate formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1710410.0A
Other versions
GB2563899A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mueller Werner Ernst Ludwig
Original Assignee
Mueller Werner Ernst Ludwig
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mueller Werner Ernst Ludwig filed Critical Mueller Werner Ernst Ludwig
Priority to GB1710410.0A priority Critical patent/GB2563899A/en
Publication of GB201710410D0 publication Critical patent/GB201710410D0/en
Publication of GB2563899A publication Critical patent/GB2563899A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1710410.0A 2017-06-29 2017-06-29 Inorganic polyphosphate formulations for use in the treatment of Alzheimer disease Withdrawn GB2563899A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1710410.0A GB2563899A (en) 2017-06-29 2017-06-29 Inorganic polyphosphate formulations for use in the treatment of Alzheimer disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1710410.0A GB2563899A (en) 2017-06-29 2017-06-29 Inorganic polyphosphate formulations for use in the treatment of Alzheimer disease

Publications (2)

Publication Number Publication Date
GB201710410D0 true GB201710410D0 (en) 2017-08-16
GB2563899A GB2563899A (en) 2019-01-02

Family

ID=59592723

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1710410.0A Withdrawn GB2563899A (en) 2017-06-29 2017-06-29 Inorganic polyphosphate formulations for use in the treatment of Alzheimer disease

Country Status (1)

Country Link
GB (1) GB2563899A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023504191A (en) * 2019-12-04 2023-02-01 ザ・ボード・オブ・トラスティーズ・オブ・ザ・リーランド・スタンフォード・ジュニア・ユニバーシティ Enhancement of blood-brain barrier drug transport by targeting endogenous regulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2532283A (en) * 2014-11-17 2016-05-18 Ernst Ludwig Georg Muller Werner Morphogenetically active calcium polyphosphate nanoparticles
GB2552649A (en) * 2016-07-25 2018-02-07 Ernst Ludwig Georg Muller Werner Amorphous strontium polyphosphate microparticles for treatment of osteoporosis and inducing bone cell mineralization

Also Published As

Publication number Publication date
GB2563899A (en) 2019-01-02

Similar Documents

Publication Publication Date Title
IL256175A (en) Use of exosomes for the treatment of disease
IL247085B (en) Methods of treating alzheimer's disease
EP3268086A4 (en) Lsd for the treatment of alzheimer's disease
IL260352B (en) Methods and compositions for the treatment of neurologic disease
IL266047A (en) Methods and compositions for the treatment of fabry disease
IL254142B (en) Tradipitant for use in the treatment of a tradipitant-responsive disease or condition
ZA201605341B (en) Methods of treating alzheimer's disease
IL262834B (en) Benzenesulfonamide compounds and their use as therapeutic agents
IL267143A (en) Benzenesulfonamide compounds and their use as therapeutic agents
GB201617064D0 (en) Compounds and their therapeutic use
HUE056265T2 (en) Igmesine for use in the treatment of alzheimer's disease
IL265911A (en) Apilimod compositions and methods for using same in the treatment of alzheimer's disease
PL3137097T3 (en) Treatment and prevention of alzheimer's disease (ad)
IL254252A0 (en) Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer's disease
PL3352742T3 (en) Compositions comprising triterpenoids for the treatment of alzheimer's disease and parkinson's disease
PL3137094T3 (en) Treatment and prevention of alzheimer's disease (ad)
IL262902B (en) Prion protein-dendrimer conjugates for use in treatment of alzheimer disease
GB201710410D0 (en) Inorganic polyphosphate formulations for use in the treatment of alzheimer disease
HUE037501T2 (en) Treatment and prevention of alzheimer's disease (ad)
SG11201607693WA (en) 6-substituted estradiol derivatives for the treatment of alzheimer's disease
ZA201801945B (en) Compositions and methods for the treatment of parkinson's disease
ZA201806894B (en) (+)-azasetron for use in the treatment of ear disorders
GB201603510D0 (en) Compositions for use in the treatment of neurological disease
GB201511453D0 (en) Treatment of alzheimer's disease
AU2015904411A0 (en) Compositions and methods for the treatment of Alzheimer's disease

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)